Literature DB >> 23763943

Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser.

Ahmed M Elsharkawy1, Ulrich Schwab, Brendan McCarron, Alastair D Burt, Ann K Daly, Mark Hudson, Steven Masson.   

Abstract

Highly active antiretroviral therapy has revolutionised HIV management. However, many of these drugs are potentially hepatotoxic. Here, we report the first adult case of efavirenz induced acute liver failure successfully treated by liver transplantation. Furthermore, genetic analysis revealed our patient to be a slow efavirenz metaboliser, contributing to the severity of clinical presentation.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ALF; ALP; ALT; Acute liver failure; CMV; CYP2B6; DILI; Drug induced liver injury; EFV; Efavirenz; HAART; HCV; HIV; Liver transplantation; NNRTI; NRTI; OLT; TDM; acute liver failure; alanine aminotransferase; alkaline phosphatase; cytomegalovirus; drug induced liver injury; efavirenz; hepatitis C virus; highly active antiretroviral therapy; human immunodeficiency virus; non-nucleoside reverse transcriptase inhibitor; nucleoside reverse transcriptase inhibitor; orthotopic liver transplantation; therapeutic drug monitoring

Mesh:

Substances:

Year:  2013        PMID: 23763943     DOI: 10.1016/j.jcv.2013.05.003

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  6 in total

1.  Efavirenz pharmacokinetics during pregnancy and infant washout.

Authors:  Regis Kreitchmann; Stein Schalkwijk; Brookie Best; Jiajia Wang; Angela Colbers; Alice Stek; David Shapiro; Tim Cressey; Mark Mirochnick; David Burger
Journal:  Antivir Ther       Date:  2019

2.  Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.

Authors:  Zelalem Petros; Ming Ta Michael Lee; Atsushi Takahashi; Yanfei Zhang; Getnet Yimer; Abiy Habtewold; Ina Schuppe-Koistinen; Taisei Mushiroda; Eyasu Makonnen; Michiaki Kubo; Eleni Aklillu
Journal:  OMICS       Date:  2017-04

3.  Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in ethiopian patients.

Authors:  Getnet Yimer; Marcus Gry; Wondwossen Amogne; Eyasu Makonnen; Abiy Habtewold; Zelalem Petros; Getachew Aderaye; Ina Schuppe-Koistinen; Lars Lindquist; Eleni Aklillu
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

Review 4.  Mechanistic insights into antiretroviral drug-induced liver injury.

Authors:  Jamie N Pillaye; Mohlopheni J Marakalala; Nonhlanhla Khumalo; Wendy Spearman; Hlumani Ndlovu
Journal:  Pharmacol Res Perspect       Date:  2020-08

5.  Macrophages Modulate Hepatic Injury Involving NLRP3 Inflammasome: The Example of Efavirenz.

Authors:  Fernando Alegre; Alberto Martí-Rodrigo; Miriam Polo; Dolores Ortiz-Masiá; Celia Bañuls; Marcello Pinti; Ángeles Álvarez; Nadezda Apostolova; Juan V Esplugues; Ana Blas-García
Journal:  Biomedicines       Date:  2022-01-05

6.  Prevalence of Cytochrome P450 2B6 Single Nucleotide Polymorphism in an HIV-Positive Cohort in Jos, Nigeria: Implication for HIV Therapy.

Authors:  A O Isaac; D D Wetkos; A O Oche; I Godwin; K Phyllis; A C John
Journal:  Niger J Clin Pract       Date:  2020-12       Impact factor: 0.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.